PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

V2 Cigs Offers Holiday Discount Coupons On All E-Cigarette Products

V2 Cigs and EcigeretteReviewed.com announce V2 Cigs Holiday Coupon Code. This allows customers to shop at 15% discount on Starter Kits and 10% off on all already-discounted E Cigarettes products.

V2 Cigs Offers Holiday Discount Coupons On All E-Cigarette Products
2012-12-09
TUSTIN, CA, December 09, 2012 (Press-News.org) V2 Cigs has been in the business of offering quality e-cigarette products for years now. It has been the trusted brand of most Americans, and has been voted as America's Number 1 Electronic Cigarette by Alexa.com. Being one of the best e cigarette brands in the market, V2 Cigs has an average of one million site visitors every month. So to give back to its millions of customers and supporters, V2 Cigs has partnered with EcigaretteReviewed.com to offer huge discounts on all of the brand's products in time for Christmas.

V2 Cigs has already dropped its prices for the coming season, but V2 Cigs Holiday Coupon Code will help customers get the most out of their V2 Shopping Carts this Christmas. This Holiday offering will offer customers up to 15% off on some of the best e-cigarette products in the market, and 10% off on all other already-discounted items. This offers customers double discounts the ultimate e-cigarette experience this Christmas.

V2 Cigs also designed a starter kit exclusively for the Holidays. The V2 Holiday Starter Kit will provide customers all the essentials so they can switch from conventional cigarettes to e-cigarettes with ease. The Holiday Starter Pack has also been marked down for this season, from $74.95 to just $49.95. It will be a great Christmas gift option this Christmas.

The V2 Holiday Starter Kit will include:

- 1 V2 Standard White Automatic Battery
- 1 V2 Standard White Manual Battery
- 5 V2 Flavor Cartridges
- 1 V2 Soft Case
- 1 Wall Adapter
- 1 Smart Charger
- 1 V2 Manual

V2 Cigs Holiday Coupon Code

To get the best deals on their e-cigarette purchases this season, customers must key in the following exclusive coupon codes upon checking out:

- ECR15KITS to save 15% on all V2 Cigs Starter Kits
- ECR10ALL to save 10% on all items in the store, including already-discounted products

Get more information on how to use the V2 Cigs promo codes.

EcigaretteReviewed.com is the first and only e-cigarette review site in the world which allows users to rank their favorite products on the site. Since 2010, the website has been educating the public on the benefits of electronic cigarettes, while encouraging them to make the switch to e-cigarettes from conventional cigarettes. The website gives users the power to rate their favorite e-cigarette products and rank them accordingly on a Top 10 chart. This allows new users to read honest user reviews and to identify the best rated e-cigarettes on the market that could help them choose the brand that best suits their needs.

Website: http://ecigarettereviewed.com

[Attachments] See images for this press release:
V2 Cigs Offers Holiday Discount Coupons On All E-Cigarette Products V2 Cigs Offers Holiday Discount Coupons On All E-Cigarette Products 2

ELSE PRESS RELEASES FROM THIS DATE:

Online Bingo at Its Best, Thanks to Bingo Reviewer!

2012-12-09
There's quite a mishmash of bingo sites, different offers, warnings about some venues, good and bad player reviews, forum posts, bonuses and other features that new players should take into consideration before they can feel confident they've made the right choice of the online bingo room where they'll deposit their money and play. In such a jungle where experience is an essential tool, there's a ray of light that delivers hope for those who are not willing to experiment and risk their money on just any bingo site; and the ray comes in shape of online bingo resource ...

Film Vet Ashaine Briscoe Enters the Spotlight with Quirky, Heartfelt New Shorts

Film Vet Ashaine Briscoe Enters the Spotlight with Quirky, Heartfelt New Shorts
2012-12-09
Filmmaker Ashaine Briscoe has just made her debut as a screenwriter, director, and producer--but to call her a novice would be an incredible oversight. In reality, Briscoe has been working in film for years, developing an almost preternaturally accomplished and diverse resume that includes credits as a Production Assistant, an Art Director, and more. She has worked on TV commercials and music videos, and her keen eye and visual flair have landed her design spots in leading glamour magazines. Now, however, it is Briscoe's time to shine, and to unleash the full extent of ...

Investigational agent targets gene signaling pathways to improve response for patients with CLL

2012-12-08
(ATLANTA, December 8, 2012) –The promising investigational targeted therapy ibrutinib and its mechanism of silencing gene communication pathways critical to the development of cancer may be an effective way to combat chronic lymphocytic leukemia (CLL), according to studies presented today at the 54th Annual Meeting of the American Society of Hematology (ASH). CLL is a blood cancer that causes abnormal white blood cells called lymphocytes to accumulate in the blood, bone marrow, and in the lymph nodes or other organs, causing these organs to enlarge. Approximately 15,000 ...

Researchers develop novel 3-D culture system for inflammatory breast cancer

2012-12-08
SAN ANTONIO, TX (December 8, 2012)—Inflammatory breast cancer (IBC) is a very rare and aggressive disease that progresses rapidly and is associated with a very low survival rate. To understand how this type of cancer spreads, it's crucial to characterize the interactions between cancer cells and their 3D environment. Researchers at Fox Chase Cancer Center have developed a novel, 3D culture system that mimics the environment surrounding these cancer cells. This model could be used to test new anticancer drugs capable of inhibiting the spread of IBC tumors. "The tumor ...

Studies assess genetics, modified treatment to improve outcomes, reduce toxicity

2012-12-08
(ATLANTA, December 8, 2012) – Research identifying genetic factors that affect survival of patients with blood cancers and evaluating the effectiveness of modified treatment strategies to improve outcomes while reducing toxicity will be presented today at the 54th Annual Meeting of the American Society of Hematology (ASH). While the cancer research community has seen many significant therapeutic advances over the last decade, only recently have investigators identified how patients' individual genetic makeup influences their short- and long-term response to therapy, demonstrating ...

Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients

2012-12-08
COLUMBUS, Ohio – Updated results from a Phase Ib/II clinical trial indicates that a novel therapeutic agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other therapy. The agent, ibrutinib (PCI-32765), is the first drug designed to target Bruton's tyrosine kinase (BTK), a protein essential for CLL-cell survival and proliferation. CLL is the most common form of leukemia, with about 15,000 new cases annually in the U.S. About 4,400 Americans die of the disease each year. Study co-leader Dr. ...

137 new species described by California Academy of Sciences in 2012

2012-12-08
SAN FRANCISCO (December 6, 2012) — In 2012, researchers at the California Academy of Sciences added 137 new relatives to our family tree, enriching our understanding of the complex web of life on Earth and strengthening our ability to make informed conservation decisions. The new species include 83 arthropods, 41 fishes, seven plants, four sea slugs, one reptile, and one amphibian. Specimens ranged from Eviota goby fishes housed in museum collections for more than 30 years (reported in the October 12 issue of Zootaxa), to Trogloraptor cave spiders collected just two years ...

Mayo Clinic IDs genes that predict whether trastuzumab will work for breast cancer patients

2012-12-08
SAN ANTONIO, Texas -- Adding the drug trastuzumab to chemotherapy prevents cancer recurrence and improves survival in a large number of women with early stage HER2-positive breast cancer. But trastuzumab does not stop tumors from returning in about 25 percent of patients — and oncologists haven't been able to identify these women before treatment. This situation may soon change, according to a Mayo Clinic study being presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium. VIDEO ALERT: Video of Dr. Perez is available on the Mayo Clinic News Network. A team ...

New small molecule inhibitor could be a safe and first-line treatment for metastatic breast cancer

2012-12-08
SAN ANTONIO, TX (December 7, 2012)—Previous research has shown that a family of genes, proteins and enzymes called the uPA system (for urokinase plasminogen activator) plays an active role in different facets of cancer's biology, including tumor cell invasion, the spread of metastases, and the growth of a primary tumor. Mesupron® is a new small molecule inhibitor, taken as a pill, that inhibits the uPA system. The results from a recent phase II clinical study suggest that the drug could be a safe and first-line treatment that extends progression-free survival for metastatic ...

Green scientists propose safety testing system for development of new chemicals

2012-12-08
PITTSBURGH—A group of scientists from North America and Europe, including Carnegie Mellon University's Terry Collins, has developed a five-tiered testing system that manufacturers can use to ensure that the chemicals and consumer products they produce are free of harmful endocrine disrupting chemicals like BPA or DDT. Their study, "Designing Endocrine Disruption Out of the Next Generation of Chemicals," will be published in the January 2013 issue of the Royal Society of Chemistry journal Green Chemistry, and is currently available online. Endocrine disrupting chemicals, ...

LAST 30 PRESS RELEASES:

Scientists track evolution of pumice rafts after 2021 underwater eruption in Japan

The future of geothermal for reliable clean energy

Study shows end-of-life cancer care lacking for Medicare patients

Scented wax melts may not be as safe for indoor air as initially thought, study finds

Underwater mics and machine learning aid right whale conservation

Solving the case of the missing platinum

Glass fertilizer beads could be a sustained nutrient delivery system

Biobased lignin gels offer sustainable alternative for hair conditioning

Perovskite solar cells: Thermal stresses are the key to long-term stability

University of Houston professors named senior members of the National Academy of Inventors

Unraveling the mystery of the missing blue whale calves

UTA partnership boosts biomanufacturing in North Texas

Kennesaw State researcher earns American Heart Association award for innovative study on heart disease diagnostics

Self-imaging of structured light in new dimensions

Study highlights successes of Virginia’s oyster restoration efforts

Optimism can encourage healthy habits

Precision therapy with microbubbles

LLM-based web application scanner recognizes tasks and workflows

Pattern of compounds in blood may indicate severity of gestational hypertension and preeclampsia

How does innovation policy respond to the challenges of a changing world?

What happens when a diet targets ultra-processed foods?

University of Vaasa, Finland, conducts research on utilizing buildings as energy sources

Stealth virus: Zika virus builds tunnels to covertly infect cells of the placenta

The rising tide of sand mining: a growing threat to marine life

Contemporary patterns of end-of-life care among Medicare beneficiaries with advanced cancer

Digital screen time and nearsightedness

Postoperative weight loss after anti-obesity medications and revision risk after joint replacement

New ACS research finds low uptake of supportive care at the end-of-life for patients with advanced cancer

New frailty measurement tool could help identify vulnerable older adults in epic

Co-prescribed stimulants, opioids linked to higher opioid doses

[Press-News.org] V2 Cigs Offers Holiday Discount Coupons On All E-Cigarette Products
V2 Cigs and EcigeretteReviewed.com announce V2 Cigs Holiday Coupon Code. This allows customers to shop at 15% discount on Starter Kits and 10% off on all already-discounted E Cigarettes products.